Mi Panpan, Dong Haoran, Chen Shengle, Gao Xuan, Cao Xu, Liu Yong, Wang Huijie, Fan Guofeng
Department of Orthopedic, Hebei PetroChina Central Hospital, Langfang, China.
Hospital of Stomatology Hebei Medical University, Shijiazhuang, China.
Front Med (Lausanne). 2024 Mar 11;11:1340037. doi: 10.3389/fmed.2024.1340037. eCollection 2024.
High-density lipoprotein cholesterol (HDL-C) has been reported to be associated with pain symptoms of various diseases, and its anti-inflammatory and antioxidant mediation is related to the pathogenesis of chronic pain. This study aims to evaluate the relationship between HDL-C levels and chronic pain in American adults.
This cross-sectional study used data from American adults aged 20 and above during the 2003-2004 National Health and Nutrition Examination Survey (NHANES) cycle. Participants were divided into 4 groups based on HDL-C quartiles. We used chi-square tests and Student's t-tests or Mann-Whitney U tests to analyze categorical variables and continuous variables to compare differences between groups. Multivariate logistic regression analysis was used to study the association between HDL-C levels and the risk of chronic pain. Likelihood ratio tests were used to assess interactions between subgroups, and sensitivity analyses were conducted.
Our final analysis included 4,688 participants, of which 733 (16.4%) had chronic pain. In the multivariate logistic regression model adjusted for covariates, there was a negative correlation between HDL-C levels and chronic pain. Specifically, for every 20 unit increase in HDL-C, the risk of chronic pain decreased by 26%. Compared with the lowest HDL-C quartile (< 43 mg/dL), the highest HDL-C quartile (≥ 64 mg/dL) was associated with a 24% reduction in the risk of chronic pain. No interaction factors affecting the relationship between HDL-C and chronic pain were found in the subgroup analysis.
This study demonstrates a negative association between HDL-C levels and chronic pain in US adults, providing insights into the pathogenesis of chronic pain and potential improvements in chronic pain management strategies.
据报道,高密度脂蛋白胆固醇(HDL-C)与多种疾病的疼痛症状相关,其抗炎和抗氧化作用与慢性疼痛的发病机制有关。本研究旨在评估美国成年人HDL-C水平与慢性疼痛之间的关系。
这项横断面研究使用了2003 - 2004年美国国家健康与营养检查调查(NHANES)周期中20岁及以上美国成年人的数据。参与者根据HDL-C四分位数分为4组。我们使用卡方检验、学生t检验或曼-惠特尼U检验来分析分类变量和连续变量,以比较组间差异。多因素逻辑回归分析用于研究HDL-C水平与慢性疼痛风险之间的关联。似然比检验用于评估亚组间的相互作用,并进行了敏感性分析。
我们的最终分析纳入了4688名参与者,其中733人(16.4%)患有慢性疼痛。在调整协变量的多因素逻辑回归模型中,HDL-C水平与慢性疼痛呈负相关。具体而言,HDL-C每增加20个单位,慢性疼痛风险降低26%。与最低HDL-C四分位数(< 43 mg/dL)相比,最高HDL-C四分位数(≥ 64 mg/dL)与慢性疼痛风险降低24%相关。亚组分析未发现影响HDL-C与慢性疼痛关系的相互作用因素。
本研究表明美国成年人HDL-C水平与慢性疼痛之间存在负相关,为慢性疼痛的发病机制及慢性疼痛管理策略的潜在改进提供了见解。